INDUSTRY INSIGHTS YOUR PEERS ARE READING
To such an extent that millions have already swapped their traditional pharmaceuticals for this high-power, low-risk organic […]. As the cannabis revolution continues to sweep the world, the wonders of CBD are becoming common knowledge. MORE
Food and Drug Administration ( FDA ) announced its first-ever approval of a marijuana-derived pharmaceutical drug On June 25, 2018, the U.S. MORE
On October 15, 2017, the Washington Post and 60 Minutes released a scathing report on the pharmaceutical industry’s influence of the Drug Enforcement Administration (DEA). MORE
Open expedited tender for the supply of 400 kg cannabis for the needs of the Florence Chemical Pharmaceutical Plant. of Legislative Decree 50/2016, by awarding separate lots for the presumed supply of 400 kg of cannabis for the needs of the Florence Chemical Pharmaceutical Factory. MORE
Intellectual property (IP) includes everything from inventions, creations, designs, processes, art, and music, and even extends to pharmaceuticals and genes- and IP is protected via a patent, trademark, or copyright, depending on the type of intellectual property it […]. MORE
CSE: BBT) (FSE: BBW) (OTC Pink: BHHKF) (“Benchmark”, “BBT” or the “Company”) a federally-licensed producer and distributor of medical-grade cannabis, is pleased to report that it has signed a definitive agreement with China-based Zhejiang Yatai Pharmaceutical Co., MORE
Press Release: Thailand Government Pharmaceutical Organization. Dr. Sophon Mektana, Advisor to the Minister of Public Health And the Chairman of the Pharmaceutical Organization Committee. Dr. Vitoon Danwiboon, Director of the Pharmaceutical Organization. MORE
can refocus its regulatory approach to pharmaceuticals, adapted from the one used in Europe, to better connect the value prescription drugs provide and their price. Cannabis Medical Marijuana News RX Affordable Care Act Donald Trump drugs FDA Germany health care opioids pharmaceuticals MORE
Food and Drug Administration ( FDA ) announced its first-ever approval of a marijuana-derived pharmaceutical drug On June 25, 2018, the U.S. MORE
Our veterans deserve the option to legally access a botanical product that is objectively safer than the litany of pharmaceutical drugs it could replace. In the House, Representative Earl Blumenauer (D-OR), a founder and co-Chair of the Congressional Cannabis Caucus, has reintroduced H.R. MORE
Conventional pharmaceuticals commonly used to treat pain sometimes have a negative impact on the immune system, GI tract, liver, and kidneys. MORE
The use of pharmaceutical cannabinoid products in Singapore comes under strict frameworks and regulations and does not diminish the country’s zero-tolerance position against drugs, the Home Affairs and Health ministries have said. The Straits Times Reports. MORE
” SB1719, which passed unanimously through both the House of Delegates and Virginia Senate, will also allow Virginia’s licensed pharmaceutical processors to transfer products between the five state-authorized facilities, ensuring that patients have access to a wider range of products. MORE
Consumers Are Replacing Pharmaceuticals With Medical Marijuana In recent years, certain states that have medical and/or recreational cannabis programs in place have experienced decreases in the number of opioid overdoses. Cannabis Medical Marijuana News opioids pharmaceuticals MORE
In June 2018, the Food and Drug Administration ( FDA ) gave its blessing to “Epidiolex,” a purfied CBD pharmaceutical, for treating severe pediatric epilepsy. MORE
The acquisition brings together Canopy Growth‘s medical business with Europe’s largest cannabinoid-based pharmaceuticals company. C3 is a leading manufacturer and distributor of dronabinol, a registered pharmaceutical drug in Germany, Austria, Switzerland, and Denmark. Dronabinol was the first cannabinoid product in Germany that could be prescribed by the country’s physicians. In 2018, C3 supplied approximately 19,500 patients in […]. MORE
Nowadays, there’s huge ranges of beautiful foodstuffs, near enough pharmaceutical-grade tinctures, oils and products unimaginable in the 60s and 70s, though we’re sure some people had the foresight to see at least some of this coming – we wouldn’t be where we are now. MORE
Cannabis Science Decriminalization Legalization Medical Marijuana 411 Politics Prohibition Addiction Opioids PharmaceuticalAmerica is in the throes of a major crisis. Opioid addiction has taken over many parts of the country and is taking a number of lives daily. The opioid crisis is at its breaking point right now. More people are spending time in hospitals or losing their lives to opioid overdose than ever before. According to the National Institute on Read Article. MORE
A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals Right now in Australia, access to Cannabis-based treatments is heavily restricted. What will unrestricted access to Medicinal Cannabis look like in Australia? MORE
The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon. MORE
Cannatech London 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals. Ron Lipsky?—?Cannatech MORE
study shows that more and more people are giving up alcohol and pharmaceuticals in favour of cannabis use. are moving away from alcohol and pharmaceuticals in favour of cannabis use. The post New data shows Cannabis replacing Alcohol and Pharmaceuticals in the U.S. A new U.S. MORE
A word from Elad Segev, Manager of Breeding and Cultivation at MGC Pharmaceuticals. Breaking Down The Cannabis Plant was originally published in MGC Pharmaceuticals on Medium, where people are continuing the conversation by highlighting and responding to this story. MORE
This is a big moment for me and the MGC Pharmaceuticals team. Needless to say, I have been waiting a long time to write the following sentence: MGC Pharmaceuticals has just released their first product to the market. MORE
Pharmaceuticals. Crisis was originally published in MGC Pharmaceuticals on Medium, where people are continuing the conversation by highlighting and responding to this story. word ? ? from ? ? Nativ ? ? Segev, ? ? Founder ? ? & & ? ? Managing ? ? Director ? ? of ? ? MGC ? ? MORE
On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. MORE
Medicinal cannabis was legalised in portugal in June 2018 by Parliament, however only one cannabis-based medication is legal in Portugal; Sativex, produced by British firm GW Pharmaceuticals. If you wish to re-publish this story please do so with following accreditation. AUTHOR: Mark Taylor. MORE
Alternative Medicine cannabis education industry Logical Fallacies medical marijuana medicine News Pharmaceuticals Science-Based Medicine Skepticism about cbd dr. roman fake placebo skeptic skeptical skepticism thc truthIt's not easy gathering my wits and going public about this. MORE
CSE: BBT ) ( FSE: BBW ) ( OTC: BHHKF ) (“Benchmark”, “BBT” or the “Company”) a federally-licensed producer and distributor of medical-grade cannabis, is pleased to report that it has signed a definitive agreement with China-based Zhejiang Yatai Pharmaceutical Co., MORE
Food and Drug Administration ( FDA ) announced its first-ever approval of a marijuana-derived pharmaceutical drug On June 25, 2018, the U.S. MORE
As you will have read in reports post new year Thailand was worried by patent requests by two foreign firms, British giant GW Pharmaceuticals and Japan’s Otsuka Pharmaceutical, filed before the change to the law. MORE
To create, develop and market a variety of high content cannabinoid based pharmaceuticals, natural health products and cosmetics for international markets. About Zhejiang Yatai Pharmaceutical Co., Zhejiang Yatai Pharmaceutical Co., MORE
Here’s the press release. The research will focus on the optimisation of breeding and cultivating processes and the extraction of material to assess their efficacy of medical cannabis on prostate, melanoma and other cancer cells. All intellectual property from the trials will be owned by MGC, which is funding the research. MORE
MXC’s fourth division: MGC Nutraceuticals MGC Pharmaceuticals will be taking its first step into the world of nutraceuticals with the creation of our new brand, MGC Nutraceuticals. MORE
The FDA has approved a pharmaceutical version of CBD to treat rare seizure disorders. NEW YORK — U.S. regulators are planning a public hearing to collect more information on CBD in cosmetics, foods and other products as the cannabis compound spreads in popularity. MORE
A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals. Thursday March 29 was a day of celebration on MGC Pharma’s timeline as we announced the commencement of production for the first batch of CannEpil™. CannEpil™?—?CBD-based MORE
How will the DEA reschedule CBD now that Epidiolex has been approved as a pharmaceutical CBD isolate? With Congress seemingly poised to legalize the cultivation of industrial hemp for many uses, including the production of biomass for CBD oil extraction, many questions remain unanswered. MORE
Armed with a well-developed agricultural sector, high environmental standards, world class pharmaceutical manufacturing standards, a like-minded government, and grassroot support for the industry, there can be no doubt that Australia is poised to become a Medical Cannabis powerhouse. MORE
Epidiolex , the first cannabis pharmaceutical to be approved by the U.S. patients this fall, following rescheduling, which is expected to occur within 90 days of FDA approval,” said GW Pharmaceuticals’ CEO Justin Gover. “We Investments in plants for processing industrial hemp and pharmaceutical cannabis is currently in progress in Greece, says Dionysis Sarmazanidis, the director of Cannatec Greece, a company leading the sector. Marijuana – it’s a numbers game. MORE
MGC Pharmaceuticals is committed to furthering the awareness of Cannabis’ treatment benefits, and we only hope that with greater investment in R&D on our own soil, one day soon our own medical system can provide the pain relief our growing population deserves. MORE
Millions of Americans are legally replacing pharmaceuticals with cannabis and the question of affordability has become critical. Are you paying too much for medical marijuana? MORE
Pharmaceutical Related Topics 
The Fresh Toast
MARCH 20, 2019
Consumers Are Replacing Pharmaceuticals With Medical Marijuana In recent years, certain states that have medical and/or recreational cannabis programs in place have experienced decreases in the number of opioid overdoses. Cannabis Medical Marijuana News opioids pharmaceuticals
Canna Newswire
MAY 21, 2019
To create, develop and market a variety of high content cannabinoid based pharmaceuticals, natural health products and cosmetics for international markets. About Zhejiang Yatai Pharmaceutical Co., Zhejiang Yatai Pharmaceutical Co.,
Canna Newswire
MAY 30, 2019
CSE: BBT ) ( FSE: BBW ) ( OTC: BHHKF ) (“Benchmark”, “BBT” or the “Company”) a federally-licensed producer and distributor of medical-grade cannabis, is pleased to report that it has signed a definitive agreement with China-based Zhejiang Yatai Pharmaceutical Co.,
Leaf Science
DECEMBER 28, 2018
study shows that more and more people are giving up alcohol and pharmaceuticals in favour of cannabis use. are moving away from alcohol and pharmaceuticals in favour of cannabis use. The post New data shows Cannabis replacing Alcohol and Pharmaceuticals in the U.S. A new U.S.
Cannabis Law Report
MAY 30, 2019
CSE: BBT) (FSE: BBW) (OTC Pink: BHHKF) (“Benchmark”, “BBT” or the “Company”) a federally-licensed producer and distributor of medical-grade cannabis, is pleased to report that it has signed a definitive agreement with China-based Zhejiang Yatai Pharmaceutical Co.,
Cannabis Law Report
JUNE 5, 2019
Press Release: Thailand Government Pharmaceutical Organization. Dr. Sophon Mektana, Advisor to the Minister of Public Health And the Chairman of the Pharmaceutical Organization Committee. Dr. Vitoon Danwiboon, Director of the Pharmaceutical Organization.
|
The Fresh Toast
FEBRUARY 8, 2019
can refocus its regulatory approach to pharmaceuticals, adapted from the one used in Europe, to better connect the value prescription drugs provide and their price. Cannabis Medical Marijuana News RX Affordable Care Act Donald Trump drugs FDA Germany health care opioids pharmaceuticals
Nature's Way Medicine
MARCH 3, 2018
Alternative Medicine cannabis education industry Logical Fallacies medical marijuana medicine News Pharmaceuticals Science-Based Medicine Skepticism about cbd dr. roman fake placebo skeptic skeptical skepticism thc truthIt's not easy gathering my wits and going public about this.
Medical Marijuana 411
MARCH 18, 2019
Cannabis Science Decriminalization Legalization Medical Marijuana 411 Politics Prohibition Addiction Opioids PharmaceuticalAmerica is in the throes of a major crisis. Opioid addiction has taken over many parts of the country and is taking a number of lives daily. The opioid crisis is at its breaking point right now. More people are spending time in hospitals or losing their lives to opioid overdose than ever before. According to the National Institute on Read Article.
Cannabis Law Report
FEBRUARY 26, 2019
Medicinal cannabis was legalised in portugal in June 2018 by Parliament, however only one cannabis-based medication is legal in Portugal; Sativex, produced by British firm GW Pharmaceuticals. If you wish to re-publish this story please do so with following accreditation. AUTHOR: Mark Taylor.
Freedom Leaf
OCTOBER 15, 2018
On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances.
|
|
Project CBD
NOVEMBER 26, 2018
Food and Drug Administration ( FDA ) announced its first-ever approval of a marijuana-derived pharmaceutical drug On June 25, 2018, the U.S.
Project CBD
NOVEMBER 26, 2018
Food and Drug Administration ( FDA ) announced its first-ever approval of a marijuana-derived pharmaceutical drug On June 25, 2018, the U.S.
Project CBD
NOVEMBER 26, 2018
Food and Drug Administration ( FDA ) announced its first-ever approval of a marijuana-derived pharmaceutical drug On June 25, 2018, the U.S.
Project CBD
MAY 1, 2019
Conventional pharmaceuticals commonly used to treat pain sometimes have a negative impact on the immune system, GI tract, liver, and kidneys.
Project CBD
JULY 31, 2018
How will the DEA reschedule CBD now that Epidiolex has been approved as a pharmaceutical CBD isolate? With Congress seemingly poised to legalize the cultivation of industrial hemp for many uses, including the production of biomass for CBD oil extraction, many questions remain unanswered.
MGC Pharma
MARCH 13, 2018
MXC’s fourth division: MGC Nutraceuticals MGC Pharmaceuticals will be taking its first step into the world of nutraceuticals with the creation of our new brand, MGC Nutraceuticals.
MGC Pharma
APRIL 4, 2018
A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals. Thursday March 29 was a day of celebration on MGC Pharma’s timeline as we announced the commencement of production for the first batch of CannEpil™. CannEpil™?—?CBD-based
Project CBD
JULY 31, 2018
In June 2018, the Food and Drug Administration ( FDA ) gave its blessing to “Epidiolex,” a purfied CBD pharmaceutical, for treating severe pediatric epilepsy.
LIWTS
FEBRUARY 24, 2019
To such an extent that millions have already swapped their traditional pharmaceuticals for this high-power, low-risk organic […]. As the cannabis revolution continues to sweep the world, the wonders of CBD are becoming common knowledge.
MGC Pharma
FEBRUARY 21, 2018
Armed with a well-developed agricultural sector, high environmental standards, world class pharmaceutical manufacturing standards, a like-minded government, and grassroot support for the industry, there can be no doubt that Australia is poised to become a Medical Cannabis powerhouse.
MGC Pharma
NOVEMBER 1, 2017
This is a big moment for me and the MGC Pharmaceuticals team. Needless to say, I have been waiting a long time to write the following sentence: MGC Pharmaceuticals has just released their first product to the market.
Americans for Safe Access
OCTOBER 17, 2017
On October 15, 2017, the Washington Post and 60 Minutes released a scathing report on the pharmaceutical industry’s influence of the Drug Enforcement Administration (DEA).
Cannabis Chronicles
APRIL 2, 2019
The FDA has approved a pharmaceutical version of CBD to treat rare seizure disorders. NEW YORK — U.S. regulators are planning a public hearing to collect more information on CBD in cosmetics, foods and other products as the cannabis compound spreads in popularity.
Cannabis Life Network
MAY 5, 2019
The acquisition brings together Canopy Growth‘s medical business with Europe’s largest cannabinoid-based pharmaceuticals company. C3 is a leading manufacturer and distributor of dronabinol, a registered pharmaceutical drug in Germany, Austria, Switzerland, and Denmark. Dronabinol was the first cannabinoid product in Germany that could be prescribed by the country’s physicians. In 2018, C3 supplied approximately 19,500 patients in […].
MGC Pharma
FEBRUARY 22, 2018
MGC Pharmaceuticals is committed to furthering the awareness of Cannabis’ treatment benefits, and we only hope that with greater investment in R&D on our own soil, one day soon our own medical system can provide the pain relief our growing population deserves.
MGC Pharma
FEBRUARY 15, 2018
A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals Right now in Australia, access to Cannabis-based treatments is heavily restricted. What will unrestricted access to Medicinal Cannabis look like in Australia?
NORML
MARCH 14, 2019
Our veterans deserve the option to legally access a botanical product that is objectively safer than the litany of pharmaceutical drugs it could replace. In the House, Representative Earl Blumenauer (D-OR), a founder and co-Chair of the Congressional Cannabis Caucus, has reintroduced H.R.
Leafwell
JULY 17, 2017
Nowadays, there’s huge ranges of beautiful foodstuffs, near enough pharmaceutical-grade tinctures, oils and products unimaginable in the 60s and 70s, though we’re sure some people had the foresight to see at least some of this coming – we wouldn’t be where we are now.
NORML
JUNE 13, 2019
Millions of Americans are legally replacing pharmaceuticals with cannabis and the question of affordability has become critical. Are you paying too much for medical marijuana?
Cannabis Law Report
JANUARY 28, 2019
As you will have read in reports post new year Thailand was worried by patent requests by two foreign firms, British giant GW Pharmaceuticals and Japan’s Otsuka Pharmaceutical, filed before the change to the law.
MGC Pharma
DECEMBER 12, 2017
A word from Elad Segev, Manager of Breeding and Cultivation at MGC Pharmaceuticals. Breaking Down The Cannabis Plant was originally published in MGC Pharmaceuticals on Medium, where people are continuing the conversation by highlighting and responding to this story.
MGC Pharma
NOVEMBER 21, 2017
Cannatech London 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals. Ron Lipsky?—?Cannatech
MGC Pharma
NOVEMBER 15, 2017
Pharmaceuticals. Crisis was originally published in MGC Pharmaceuticals on Medium, where people are continuing the conversation by highlighting and responding to this story. word ? ? from ? ? Nativ ? ? Segev, ? ? Founder ? ? & & ? ? Managing ? ? Director ? ? of ? ? MGC ? ?
Cannabis Law Report
JUNE 7, 2019
The use of pharmaceutical cannabinoid products in Singapore comes under strict frameworks and regulations and does not diminish the country’s zero-tolerance position against drugs, the Home Affairs and Health ministries have said. The Straits Times Reports.
NORML
FEBRUARY 14, 2019
” SB1719, which passed unanimously through both the House of Delegates and Virginia Senate, will also allow Virginia’s licensed pharmaceutical processors to transfer products between the five state-authorized facilities, ensuring that patients have access to a wider range of products.
MGC Pharma
FEBRUARY 20, 2018
The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.
Cannabis Life Network
JANUARY 24, 2019
Intellectual property (IP) includes everything from inventions, creations, designs, processes, art, and music, and even extends to pharmaceuticals and genes- and IP is protected via a patent, trademark, or copyright, depending on the type of intellectual property it […].
Cannabis Law Report
JUNE 21, 2019
Open expedited tender for the supply of 400 kg cannabis for the needs of the Florence Chemical Pharmaceutical Plant. of Legislative Decree 50/2016, by awarding separate lots for the presumed supply of 400 kg of cannabis for the needs of the Florence Chemical Pharmaceutical Factory.
NewsMunchies
SEPTEMBER 5, 2018
Epidiolex , the first cannabis pharmaceutical to be approved by the U.S. patients this fall, following rescheduling, which is expected to occur within 90 days of FDA approval,” said GW Pharmaceuticals’ CEO Justin Gover. “We Investments in plants for processing industrial hemp and pharmaceutical cannabis is currently in progress in Greece, says Dionysis Sarmazanidis, the director of Cannatec Greece, a company leading the sector. Marijuana – it’s a numbers game.
86 
Let's personalize your content